Share-Based Compensation	9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation	Share-Based Compensation Market-based Performance NQSOs On March 5, 2025, the Company granted options to purchase a total of 466 ordinary shares with market conditions to executive officers. The options shall vest in four equal increments if the volume-weighted average price of the Company’s ordinary shares during any 30-calendar day period over the five years after the grant date exceeds $11.00, $14.00, $17.00 and $19.09, respectively. The weighted average grant-date fair value per share of the market-based NQSOs was $6.15. A total of 233 market-based NQSOs vested during the three and nine months ended September 30, 2025. As of September 30, 2025, 233 market-based NQSOs were still outstanding. Share-based compensation expense related to market-based NQSOs was approximately $900 for the three months ended September 30, 2025 and $2,200 for the nine months ended September 30, 2025.

Share-Based Compensation

9 Months Ended

Sep. 30, 2025

Share-Based Payment Arrangement [Abstract]

Market-based Performance NQSOs

On March 5, 2025, the Company granted options to purchase a total of 466 ordinary shares with market conditions to executive officers. The options shall vest in four equal increments if the volume-weighted average price of the Company’s ordinary shares during any 30-calendar day period over the five years after the grant date exceeds $11.00, $14.00, $17.00 and $19.09, respectively. The weighted average grant-date fair value per share of the market-based NQSOs was $6.15. A total of 233 market-based NQSOs vested during the three and nine months ended September 30, 2025. As of September 30, 2025, 233 market-based NQSOs were still outstanding.

Share-based compensation expense related to market-based NQSOs was approximately $900 for the three months ended September 30, 2025 and $2,200 for the nine months ended September 30, 2025.